Last reviewed · How we verify

NCT05640921

Group-integrated Cognitive Behavioural Therapy (Gi-CBT) to Aid Communities' Reintegration of Former Terrorists in Nigeria: A Randomised Control Trial

Status unknown NA Last updated 7 December 2022
What this trial tests

NA trial testing Gi-CBT in Depression in 24 participants. Status unknown.

Timeline
20 December 2022
Primary endpoint
30 November 2023
30 November 2023

Quick facts

Lead sponsorTeesside University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment24
Start date20 December 2022
Primary completion30 November 2023
Estimated completion30 November 2023

Drugs / interventions tested

Conditions studied

Sponsor

Teesside University

Who can join

18 and older, any sex, with Depression or Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project aims to make significant contributions that change the conversation in communities and policy circles through promoting knowledge of nonviolent peace strategies using the Group integrated Cognitive Behavioural Therapy (Gi-CBT) to help heal trauma, improve peace, and encourage positive rehabilitation and reintegration of former Boko Haram terrorists' members and their families.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Teesside University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05640921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing